Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.

MLA

Visscher, Henk, et al. “Genetic Variants in SLC22A17 and SLC22A7 Are Associated with Anthracycline-Induced Cardiotoxicity in Children.” Pharmacogenomics, vol. 16, no. 10, 2015, pp. 1065–76. EBSCOhost, https://doi.org/10.2217/pgs.15.61.

APA

Visscher, H., Rassekh, S. R., Sandor, G. S., Caron, H. N., van Dalen, E. C., Kremer, L. C., van der Pal, H. J., Rogers, P. C., Rieder, M. J., Carleton, B. C., Hayden, M. R., & Ross, C. J. (2015). Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics, 16(10), 1065–1076. https://doi.org/10.2217/pgs.15.61

Chicago

Visscher, Henk, S Rod Rassekh, George S Sandor, Huib N Caron, Elvira C van Dalen, Leontien C Kremer, Helena J van der Pal, et al. 2015. “Genetic Variants in SLC22A17 and SLC22A7 Are Associated with Anthracycline-Induced Cardiotoxicity in Children.” Pharmacogenomics 16 (10): 1065–76. doi:10.2217/pgs.15.61.